November/December 2025 | Ocular Oncology
Choroidal Metastasis From Lung Adenocarcinoma
Diagnosis of choroidal malignancy should prompt a workup for systemic disease in patients with no known history of cancer.
Weilin Song, MD; Julie K. Kwon, MD; Basil K. Williams Jr, MD; and Jayanth Sridhar, MD
September 2025 | Ocular Oncology
Reducing Chemotherapy Duration for High-Risk Retinoblastoma
Three cycles may offer comparable clinical benefit to six cycles while reducing treatment burden.
Madison M. Woods, BA; Robert J. Medina, BA; and Carol L. Shields, MD
July/August 2025 | Ocular Oncology
Surgical Management of Retinal Detachment in Uveal Melanoma
Addressing this complication requires careful planning and follow-up.
Rodrigo Anguita, MBBS, MD, FEBO, FICO, and Lyndon da Cruz, MA, MBBS, PhD, FRCOphth, FRACO
March 2025 | Ocular Oncology
Neoplastic Masqueraders of Uveitis
Remember these various ocular malignancies as you prepare your differential diagnosis.
Ioanna Ploumi, MSc; Konstantina Riri, MD, MSc; and Sofia Androudi, MD, PhD
January/February 2025 | Ocular Oncology
Does Iris Color Matter in Uveal Melanoma?
Research confirms that light eyes are a risk factor.
Charles DeYoung, BA; Alexandra R. Zaloga, BA; Rolika Bansal, MD; and Carol L. Shields, MD
October 2024 | Ocular Oncology
Tissue Glue-Assisted Plaque Radiotherapy for Uveal Melanoma
A potentially safer approach for eyes with a thin sclera.
Robert J. Medina, BA; Madison M. Woods, BA; Rolika Bansal, MD; and Carol L. Shields, MD
September 2024 | Ocular Oncology
Combination Therapy for Metastatic Uveal Melanoma
A look at the response of large choroidal metastatic melanoma to treatment with darovasertib and crizotinib.
Lauren B. Yeager, MD, and Brian P. Marr, MD
July/August 2024 | Ocular Oncology
A Masquerade: Leukemia Retinopathy or Viral Infection?
Ocular symptoms thought to be related to malaria turned out to be signs of systemic malignancy.
Brian Wollocko, MD; Samuel Gelnick, MD; and Eric Shrier, DO, FAAO
April 2024 | Ocular Oncology
Ocular Effects of CAR-T Cell Therapy
Know the risks and potential therapeutic benefits associated with this treatment modality.
Lars H. Andersen, MD; Jaskirat S. Takhar, MD; and Jose J. Echegaray, MD
March 2024 | Ocular Oncology
Conditional Survival of Patients With Uveal Melanoma
Factoring in years of metastasis-free survival may lead to an improved prognosis.
Harrison S. Fellheimer, BA; Madison M. Woods, BA; Joseph D. DeSimone, BS; and Carol L. Shields, MD
January/February 2024 | Ocular Oncology
Ocular Toxicity of New-Age Cancer Therapies
Because modern medications may induce immune-related ocular adverse events, a collaborative approach is important when caring for these patients.
Ronak Shah, BS; Robin A. Vora, MD; Amar Patel, MD; and Ying Qian, MD
October 2023 | Ocular Oncology
Choroidal Melanoma: Does Skin Tone Matter?
The literature shows that Fitzpatrick skin type can affect the prognosis and outcomes of cancers.
Irwin Leventer, BA; Kevin R. Card, BS; and Carol L. Shields, MD
March 2023 | Ocular Oncology
Beware of Congenital Pigmented Ocular Findings
These could indicate overlooked oculodermal melanocytosis, or nevus of Ota, a risk factor for uveal melanoma.
Devon Shatzman, BS; Mrittika Sen, MD; and Carol L. Shields, MD
November/December 2022 | Ocular Oncology
Intraarterial Chemotherapy for Recurrent Retinoblastoma
An excellent option for primary and secondary therapy.
Rachel S. Kim, BS; Kushal U. Agrawal, MS; and Carol L. Shields, MD
October 2022 | Ocular Oncology
Hemorrhage Over a Choroidal Nevus—Harmless or Hazardous?
Choroidal neovascularization may lead to worrisome findings on fundus autofluorescence, but these do not necessarily indicate malignancy.
Samantha Pastore, BS; Jennifer S. Zeiger, BA; Guy S. Negretti, FRCOphth; and Carol L. Shields, MD
April 2022 | Ocular Oncology
Trilateral Retinoblastoma with Suprasellar Mass
A rare case was effectively treated with high-dose chemotherapy and autologous stem cell rescue.
Catherine K. Liu, BS; Zeynep Bas, MD; and Carol L. Shields, MD
January/February 2022 | Ocular Oncology
CME Secondary to Extra-Macular Choroidal Melanoma
A rare case of ocular melanoma with retinal invasion leading to remote cystoid macular edema.
Ankur Nahar, BS; Ahmed Sheikh, MD; and Carol L. Shields, MD
November/December 2021 | Ocular Oncology
The Case of an Iris Melanoma Masquerader
A careful examination is necessary to properly diagnose iridocorneal endothelial syndrome with iris nevus.
Mallory E. Bowers, PhD; Ahmed Sheikh, MD; and Carol L. Shields, MD
View More Articles